(Q77676639)

English

Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis

scientific article published on 01 December 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

inclusion body myositis

1 reference

M C Dalakas

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

publication date

1 December 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

volume

51

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

issue

6 Suppl 5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

page(s)

S37-45

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

Identifiers

DOI

10.1212/WNL.51.6_SUPPL_5.S37

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

PubMed publication ID

9851729

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9851729

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851729%20AND%20SRC:MED&resulttype=core&format=json

(Q77676639)

Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)